# FDA Inspection 1145707 - Novitium Pharma LLC - July 08, 2021

Source: https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/0289af2b-e714-4ff0-9e89-ab2ef37687f6
Source feed: FDA_Inspections

> FDA Inspection 1145707 for Novitium Pharma LLC on July 08, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1145707
- Company Name: Novitium Pharma LLC
- Inspection Date: 2021-07-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1230049 - 2024-02-16](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/c4edb0db-e08e-4305-9915-71b848ff4d32)
- [FDA Inspection 1204308 - 2023-03-31](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/071be200-4a09-4449-947c-fe0d400d5cc8)
- [FDA Inspection 1080904 - 2019-02-04](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/39280e41-44ce-4cff-83ec-fff6aa1e07c5)
- [FDA Inspection 1053573 - 2018-05-09](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/81665580-0345-47bf-9dd3-1b0e4b693e62)

Company: https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
